So at my husband;s last biopsy (lesions on the bone) for a clinical study it was found that he now has this mutation also in addition to PTEN & TP53 . While this seems to be related to poorer OS ( like he didn't already have that going on) has anyone read anything about targeting this gene?
Thanks all,
Blair
Written by
Blair77
To view profiles and participate in discussions please or .
I found an article from 2015 that covers several mutations and treatments available. There has probably been progress made since then, but it has useful information.
RB1 is a tumor suppressor gene. Seems that it is not too uncommon for it to be silenced along with PTEN & P53 in treatment-resistant cells.
The silencing is usually due to methylation. This is an epigenetic change & is reversible in theory. There have been threads on methylation. PCa cells tend to want to be hypermethylated. Depriving them of unlimited methyl is difficult in the U.S. & countries that followed the FDA lead of fortifying grains with folic acid. Folate is the primary methyl donor.
Men with low vitamin B12 are at an "advantage", since B12 is an essential cofactor in the recycling of homocysteine that leads to SAM (SAMe), which carries methyl to cells that want it.
High doses of genistein may demethylate cells. For a while, it looked like Disulfiram (anti-alcohol drug) might be useful [1] [2], but results were disappointing.
"The three major isoflavones found in soybeans are genistein, daidzein, and glycitein. Other isoflavones found in soy include diadzin, glycitein, glycitin.". Lef.org
Patrick, you mention genistein as being helpful to reduce methylization.
Do any of the other isoflavones have similar effects?
If so wouldn't a diet consistently supplemented with edamame do the job? Though I have heard too much soy can cause unintended hormone related imbalances.
What do you think about just pure genistein supplementation?
Daidzein is rated highly, but most in the West are not equol producers, so daidzein is not an option.
Dietary soy does not deliver enough genistein & is thought to promote PCa & BCa growth. Genistein has a biphasic effect in the lab. Pharmaceutical levels are required to inhibit PCa growth.
Which is why I only use the LEF product. If you find a product with more, please let the group know.
My question with (de)methylation is what the heck are the global effects...the reactivation of wanted helpful genes also implies the activation of those not so much...all in the milieu of rapidly dividing mutating PC cells....?
There is substantial collateral damage with conventional PCa therapy. I have used the LEF product for many years without side effects. I can't say how effective it is though.
".....therapy induced progression of prostate cancer to CRPC leads to two distinct tumors subtypes based on clinicopathologic and genomic characterization."
......
........"The second subtype, aggressive variant PCa (AVPC), is phenotypically similar to small cell prostate cancer with loss of AR expression, gain of neuroendocrine or pro-neural marker expression, sensitivity to chemotherapy and combined alterations of PTEN, TP53 and RB1 tumor suppressor proteins. "
I wish you and your husband all the best. I don't think my answer is responsive to your question, but it might help explain what "RB1" is to someone (like me) who had never heard of it before.....
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.